초록 ▼

Device and methods for the removal of phospholipids from biological samples are disclosed and described. Removal of phospholipids may be desirable for the analysis of the phospholipids themselves, or to prevent the phospholipids from conflicting with and effectively masking other analytes in the sam

Device and methods for the removal of phospholipids from biological samples are disclosed and described. Removal of phospholipids may be desirable for the analysis of the phospholipids themselves, or to prevent the phospholipids from conflicting with and effectively masking other analytes in the sample for which identification or quantification is sought.

대표청구항 ▼

What is claimed is: 1. A device for removing phospholipids from a biological sample, comprising: a) a support; and b) at least one type of phospholipotropic multivalent cation coupled to the support in a concentration that is sufficient to capture and retain phospholipids from the biological sample

What is claimed is: 1. A device for removing phospholipids from a biological sample, comprising: a) a support; and b) at least one type of phospholipotropic multivalent cation coupled to the support in a concentration that is sufficient to capture and retain phospholipids from the biological sample said cation including either an actinide, or a lanthanide or a mixture thereof, said lanthanide being selected from the group consisting of: cerium, lanthanum, europium, neodymium, gadolinium, or a mixture thereof. 2. The device of claim 1, wherein the lanthanide is cerium. 3. The device of claim 1, wherein the phospholipotropic multivalent cation is coupled to the support with an attachment selected from the group consisting of an ionic bond, chelation, and combinations thereof. 4. The device of claim 3, wherein the ionic bond utilizes an acid active group. 5. The device of claim 4, wherein the acid active group is selected from the group consisting of sulfonic acid, phosphoric acid, carboxylic acid, acidic silanols acidic zirconia and combinations thereof. 6. The device of claim 1, wherein the support is an inorganic salt matrix. 7. The device of claim 1, wherein the support is a sorbent. 8. The device of claim 1, wherein the support includes a member selected from the group consisting of alumina, silica, polymers, carbon, zirconium, controlled-pore glass, diatomaceous earth, and combinations thereof. 9. The device of claim 8, wherein the support includes a functional group. 10. The device of claim 1, wherein the phospholipotropic multivalent cation retains the phospholipid until the cation is contacted with a solution that is sufficient to release the phospholipid from the cation. 11. The device of claim 1, wherein the phospholipotropic multivalent cation is coupled to the support until the cation is contacted with an agent that is sufficient to release the cation from the support. 12. A method of removing phospholipids from a biological sample, comprising: a) contacting at least one type of phospholipotropic multivalent cation selected from the group consisting of lanthanides and actinides, and coupled to a support, with the biological sample; b) capturing phospholipids in the sample with the cation by chemically coordinating including chelating or ionically associating the phospholipids with the cation; and c) separating the cation and captured phospholipids from the sample. 13. The method of claim 12, further comprising the step of separating the captured phospholipids from the cation. 14. The method of claim 13, further comprising the step of collecting the phospholipids. 15. The method of claim 12, wherein the phospholipotropic multivalent cation is a transition metal. 16. The method of claim 12, wherein the phospholipotropic multivalent cation is a lanthanide. 17. The method of claim 16, wherein the lanthanide is cerium. 18. The method of claim 12, wherein the phospholipotropic multivalent cation is an actinide. 19. The method of claim 12, wherein the phospholipotropic multivalent cation is coupled to a support. 20. The method of claim 19, wherein the support is an inorganic salt matrix. 21. The method of claim 19, wherein the support includes a member selected from the group consisting of alumina, silica, polymers, carbon, zirconium, controlled-pore glass, diatomaceous earth, and combinations thereof. 22. The method of claim 19, further comprising the step of separating the phospholipotropic multivalent cation from the support. 23. A method of making a device for removing phospholipids from a biological sample, comprising: coupling at least one type of phospholipotropic multivalent cation with a support by a mechanism selected from the group consisting of ionic bonding, covalent bonding, chemical coordination including chelation, and combinations thereof, in a manner that preserves an affinity of the cation for phospholipids and in concentration that is sufficient to capture and retain phospholipids from the biological sample, said cation including either an actinide, or a lanthanide or a mixture thereof, said lanthanide being selected from the group consisting of: cerium, lanthanum, europium, neodymium, gadolinium, or a mixture thereof. 24. The method of claim 23, wherein the cation is coupled to the support using an acid active group. 25. The method of claim 24, wherein the acid active group is selected from the group consisting of sulfonic acid, phosphoric acid, carboxylic acid, acidic silanol, acidic zirconia, and combinations thereof. 26. The method of claim 23, wherein the lanthanide is cerium. 27. The method of claim 23, wherein the support is an inorganic salt matrix. 28. The method of claim 23, wherein the support includes a member selected from the group consisting of alumina, silica, polymers, carbon, zirconium, controlled-pore glass, diatomaceous earth, and combinations thereof. 29. The method of claim 28, wherein the support includes a functional group. 30. A device for removing phospholipids from a biological sample, comprising: a) an inorganic salt matrix support; and b) at least one type of phospholipotropic multivalent cation selected from the group consisting of lanthanides and actinides coupled to the inorganic salt matrix support by a mechanism selected from the group consisting of ionic bonding, covalent bonding, chemical coordination including chelation, and combinations thereof, in a concentration that is sufficient to capture and retain phospholipids from the biological sample. 31. The device of claim 30, wherein the phospholipotropic multivalent cation is a transition metal. 32. The device of claim 30, wherein the phospholipotropic multivalent cation is a lanthanide. 33. The device of claim 32, wherein the lanthanide is cerium. 34. The device of claim 30, wherein the phospholipotropic multivalent cation is an actinide. 35. The device of claim 30, wherein the coupling is by an ionic bond. 36. The device of claim 35, wherein the ionic bond utilizes an acid active group. 37. The device of claim 36, wherein the acid active group is selected from the group consisting of sulfonic acid, phosphoric acid, carboxylic acid, acidic silanols acidic zirconia and combinations thereof. 38. The device of claim 30, wherein the phospholipotropic multivalent cation retains the phospholipid until the cation is contacted with a solution that is sufficient to release the phospholipid from the cation. 39. The device of claim 30, wherein the phospholipotropic multivalent cation is coupled to the support until the cation is contacted with an agent that is sufficient to release the cation from the support. 40. A method of removing phospholipids from a biological sample, comprising: a) contacting at least one phospholipotropic multivalent cation selected from the group consisting of lanthanides or actinides coupled to a support with the biological sample; b) capturing phospholipids in the sample with the cation; and c) separating the cation and captured phospholipids from the sample. 41. The method of claim 40, further comprising the step of separating the captured phospholipids from the cation. 42. The method of claim 41, further comprising the step of collecting the phospholipids. 43. The method of claim 40, wherein the capturing includes ionically associating the phospholipids with the phospholipotropic multivalent cation. 44. The method of claim 40, wherein the phospholipotropic multivalent cation is a lanthanide. 45. The method of claim 44, wherein the lanthanide is cerium. 46. The method of claim 40, wherein the phospholipotropic multivalent cation is coupled to a support. 47. The method of claim 46, wherein the support is an inorganic salt matrix. 48. The method of claim 46, wherein the support includes a member selected from the group consisting of alumina, silica, polymers, carbon, zirconium, controlled-pore glass, diatomaceous earth, and combinations thereof. 49. The method of claim 46, further comprising the step of separating the phospholipotropic multivalent cation from the support.